Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a clinical trial registry record with no posted results; it describes a planned interventional study testing probiotics to mitigate GI side effects of GLP-1 RAs in obesity, with estimated enrollment of 50 participants and a surrogate primary outcome (digestive quality of life).
This is a completed feasibility study of an 8-week produce prescription intervention in 40 adolescents with obesity; results are not yet reported in this registry record, and the design is uncontrolled with surrogate endpoints.
This is a completed Phase 4 interventional study with small sample size (n=25) and surrogate endpoint (remission status at 12 weeks); results are not yet reported in this registry record.